Dopamine Dysregulation in Obesity Research shows that many people with obesity have issues with the way their brains reward system works
When taken as an injectable medication, semaglutide stimulates the release of GLP-1 and suppresses appetite, resulting in fewer calories consumed and a decrease in body weight
One widely quoted study resulted in a 15% weight loss in a group of nearly 2,000 adults who participated, and most other findings seem to settle on the 15% number
Accessed November 13, 2023
BPC-157 and TB-500 are sometimes searched together because both are connected to recovery and tissue repair research categories
GLP-1 can also block the secretion of glucagon (a hormone capable of raising blood sugar levels), makes you feel full, and reduces the rate of stomach emptying (which can help your body release lower amounts of glucose into your bloodstream)